Skip To Main Content
Baran BAŞ on Muck Rack

Baran BAŞ

As seen in: Mondaq, Chambers and Partners Legal Insights, Concurrences
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Baran

Contact Baran, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Turkish Competition Authority opens a full investigation into an ice cream manufacturer for freezer cabinet exclusivity practices and imposes interim measures requiring the active reservation of 30% of cabinet space for competitor products (Unilever /

|
By Baran BAŞ, Gulce Korkmaz, Krisztián Katona
| Concurrences Verified
Estimated reading time: 7 min The Turkish Competition Board (the “TCB” or the “Board”), by its decision dated April 22, 2026, and numbered 26-15/434-162, decided to open a full investigation against Unilever Sanayi ve Ticaret Türk AŞ (“Unilever”) and Magnum Dondurma AŞ (“Magnum”) and imposed an interim measure.
Open in Who Shared Issue with article?

The Turkish Competition Authority publishes 4 updated merger control guidelines implementing the 2026 communiqué amendments on the thresholds and turnover calculations

|
By Baran BAŞ, Gulce Korkmaz, Krisztián Katona
| Concurrences Verified
Estimated reading time: 5 min In February 2026, the Communiqué No. 2010/4 on Mergers and Acquisitions Calling for the Authorization of the Competition Board (“Communiqué No. 2010/4”) has been amended. The Communiqué Amending the Communiqué No. 2010/4 on Mergers and Acquisitions Calling for the Authorization of the Competition Board (“Communiqué No. 2026/2”) was published in the Official Gazette dated February 11, 2026, and numbered 33165, entering into force on the same date.
Open in Who Shared Issue with article?

The Turkish Competition Authority unconditionally clears the transfer of a drug license and trademark rights (Humanis / AstraZeneca)

|
By Baran BAŞ, Gulce Korkmaz, Damien Gerard
| Concurrences Verified
Estimated reading time: 3 min The Turkish Competition Board (“TCB” or “the Board”), in its decision dated 31 July 2025 and numbered 25-28/659-396, unconditionally cleared the transaction whereby Humanis Sağlık A.Ş. (“Humanis”) acquired the drug license and trademark rights in Türkiye of the pharmaceutical product “Seroquel” from AstraZeneca İlaç San. ve Tic. Ltd. Şirketi (“AstraZeneca”), following a review phase of approximately one month [1]. The reasoned decision was published on 25 November 2025.
Open in Who Shared Issue with article?
See all 11 articles